We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sets May 11 Hearing on Recent Biosimilars Guidance
FDA Sets May 11 Hearing on Recent Biosimilars Guidance
March 2, 2012
The FDA will hold a one-day public hearing May 11 to get feedback on the usefulness and clarity of its recent biosimilars guidance and field comments on its next move.